Ironwood Pharmaceuticals Shares Outstanding 2009-2019 | IRWD

Ironwood Pharmaceuticals shares outstanding from 2009 to 2019. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Ironwood Pharmaceuticals Annual Shares Outstanding
(Millions of Shares)
2018 153
2017 149
2016 145
2015 142
2014 137
2013 116
2012 106
2011 100
2010 90
2009 7
2008 7
2007 7
2006 6
Ironwood Pharmaceuticals Quarterly Shares Outstanding
(Millions of Shares)
Q3 2019 156
Q2 2019 156
Q1 2019 155
Q4 2018 153
Q3 2018 153
Q2 2018 152
Q1 2018 151
Q4 2017 149
Q3 2017 150
Q2 2017 149
Q1 2017 148
Q4 2016 145
Q3 2016 145
Q2 2016 145
Q1 2016 144
Q4 2015 142
Q3 2015 142
Q2 2015 142
Q1 2015 141
Q4 2014 137
Q3 2014 139
Q2 2014 138
Q1 2014 130
Q4 2013 116
Q3 2013 121
Q2 2013 113
Q1 2013 108
Q4 2012 106
Q3 2012 114
Q2 2012 107
Q1 2012 104
Q4 2011 100
Q3 2011 100
Q2 2011 100
Q1 2011 99
Q4 2010 90
Q3 2010 98
Q2 2010 98
Q1 2010 64
Q4 2009 7
Q3 2009 7
Q2 2009 7
Q1 2009 7
Q4 2008
Q3 2008
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $1.819B $0.347B
Ironwood Pharmaceuticals is an entrepreneurial pharmaceutical company that discovers, develops, and intends to commercialize innovative human medicines. The Company's first in class compound, Linaclotide, is being evaluated in a confirmatory Phase 3 program for the treatment of irritable bowel syndrome with constipation and chronic constipation. The Company also focuses on one Phase 1 pain drug candidate and multiple preclinical programs, as well as on building a specialty biochemicals business based on a proprietary strain-development platform. Ironwood also has a growing pipeline of additional drug candidates in earlier stages of development. Ironwood is headquartered in Cambridge, Massachusetts.
Stock Name Country Market Cap PE Ratio
Takeda Pharmaceutical (TAK) Japan $62.374B 9.86
Zoetis (ZTS) United States $55.370B 33.12
Astellas Pharma (ALPMY) Japan $31.354B 15.66
Eisai (ESALY) Japan $18.833B 36.31
Merck (MKGAF) Germany $15.199B 20.74
Grifols, S.A (GRFS) Spain $14.885B 18.99
UCB SA (UCBJF) Belgium $14.669B 0.00
Neurocrine Biosciences (NBIX) United States $10.118B 477.70
Ono Pharmaceutical (OPHLF) Japan $9.450B 20.20
IPSEN SA ADR (IPSEY) France $8.953B 0.00
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $8.638B 0.00
Ionis Pharmaceuticals (IONS) United States $8.129B 16.46
Jazz Pharmaceuticals (JAZZ) Ireland $7.571B 9.67
Sage Therapeutics (SAGE) United States $7.295B 0.00
Catalent (CTLT) United States $7.185B 29.23
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.214B 0.00
Orion OYJ (ORINY) Finland $5.849B 30.12
STADA ARZNEIMI (STDAF) Germany $5.375B 0.00
Hypermarcas (HYPMY) Brazil $5.178B 18.61
Arrowhead Pharmaceuticals (ARWR) United States $4.598B 105.43
United Therapeutics (UTHR) United States $3.929B 0.00
Nektar Therapeutics (NKTR) United States $3.418B 0.00
FibroGen (FGEN) United States $3.052B 89.69
Evotec AG (EVTCY) Germany $3.051B 49.93
Taro Pharmaceutical Industries (TARO) Israel $2.937B 10.73
PTC Therapeutics (PTCT) United States $2.633B 0.00
Portola Pharmaceuticals (PTLA) United States $2.091B 0.00
Xencor (XNCR) United States $2.040B 62.00
Zogenix (ZGNX) United States $2.005B 0.00
Tilray (TLRY) Canada $1.986B 0.00
Corcept Therapeutics (CORT) United States $1.888B 22.94
Heron Therapeutics (HRTX) United States $1.877B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.777B 52.57
USANA Health Sciences (USNA) United States $1.561B 16.66
CLINIGEN GP (CLIGF) United Kingdom $1.244B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.221B 20.14
Radius Health (RDUS) United States $1.095B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.005B 0.00
Karyopharm Therapeutics (KPTI) United States $0.964B 0.00
ArQule (ARQL) United States $0.945B 0.00
Endo (ENDP) Ireland $0.943B 1.73
Spectrum Pharmaceuticals (SPPI) United States $0.907B 0.00
Aerie Pharmaceuticals (AERI) United States $0.844B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.811B 5.53
TherapeuticsMD (TXMD) United States $0.746B 0.00
Organogenesis Holdings (ORGO) United States $0.740B 0.00
Collegium Pharmaceutical (COLL) United States $0.613B 0.00
Flexion Therapeutics (FLXN) United States $0.610B 0.00
Concordia (CXRXF) Canada $0.552B 0.00
Translate Bio (TBIO) United States $0.550B 0.00
ChemoCentryx (CCXI) United States $0.508B 0.00
ImmunoGen (IMGN) United States $0.490B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.485B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.484B 58.75
Aptorum Group (APM) Hong Kong, SAR China $0.455B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.445B 0.00
OptiNose (OPTN) United States $0.413B 0.00
Dermira (DERM) United States $0.411B 0.00
Siga Technologies (SIGA) United States $0.406B 9.28
BioSpecifics Technologies Corp (BSTC) United States $0.389B 16.76
Ardelyx (ARDX) United States $0.387B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.384B 0.00
Akebia Therapeutics (AKBA) United States $0.383B 0.00
Indivior (INVVY) United States $0.378B 1.37
Lannett Co Inc (LCI) United States $0.376B 4.37
Recro Pharma (REPH) United States $0.375B 0.00
Innate Pharma SA (IPHYF) France $0.372B 0.00
DURECT (DRRX) United States $0.367B 0.00
Harpoon Therapeutics (HARP) United States $0.325B 0.00
GlycoMimetics (GLYC) United States $0.282B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.278B 0.00
Molecular Templates (MTEM) United States $0.259B 0.00
Xeris Pharmaceuticals (XERS) United States $0.215B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.211B 0.00
KalVista Pharmaceuticals (KALV) United States $0.195B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.186B 0.00
Nature's Sunshine Products (NATR) United States $0.185B 31.83
Calithera Biosciences (CALA) United States $0.181B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.175B 0.00
Jounce Therapeutics (JNCE) United States $0.175B 2.34
La Jolla Pharmaceutical (LJPC) United States $0.164B 0.00
Concert Pharmaceuticals (CNCE) United States $0.164B 0.00
Taiwan Liposome (TLC) Taiwan $0.162B 0.00
Aquestive Therapeutics (AQST) United States $0.154B 0.00
CV Sciences (CVSI) United States $0.142B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.138B 0.00
Redhill Biopharma (RDHL) Israel $0.135B 0.00
MEI Pharma (MEIP) United States $0.133B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.129B 0.00
Ocular Therapeutix (OCUL) United States $0.128B 0.00
CannTrust Holdings (CTST) Canada $0.126B 0.00
IMV INC (IMV) Canada $0.122B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.118B 0.00
Cardiome Pharma (CORV) Canada $0.111B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.093B 0.00
MediWound (MDWD) Israel $0.083B 0.00
Majesco Entertainment (PTE) United States $0.079B 0.00
Neos Therapeutics (NEOS) United States $0.078B 0.00
Otonomy (OTIC) United States $0.077B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.076B 22.64
Aclaris Therapeutics (ACRS) United States $0.074B 0.00
SCYNEXIS (SCYX) United States $0.068B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.067B 0.00
Generex Biotechnology (GNBT) United States $0.065B 0.00
Natural Alternatives (NAII) United States $0.064B 15.96
Opiant Pharmaceuticals (OPNT) United States $0.063B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.062B 0.00
Champions Oncology (CSBR) United States $0.060B 0.00
Genocea Biosciences (GNCA) United States $0.059B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.057B 0.00
Medicure (MCUJF) Canada $0.057B 0.00
Infinity Pharmaceuticals (INFI) United States $0.056B 0.00
Pharmaxis (PXSLY) Australia $0.055B 0.00
Novan (NOVN) United States $0.055B 0.00
RENEURON GP (RNUGF) United Kingdom $0.054B 0.00
IntelGenx Technologies (IGXT) Canada $0.053B 0.00
Nivalis Therapeutics (ALPN) United States $0.051B 0.00
Capnia (SLNO) United States $0.049B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.049B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.046B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.045B 0.00
ElectroCore (ECOR) United States $0.044B 0.00
CTI BioPharma (CTIC) United States $0.043B 0.00
Forward Pharma (FWP) Denmark $0.040B 0.00
Mannatechorporated (MTEX) United States $0.036B 0.00
Jaguar Animal Health (JAGX) United States $0.034B 0.00
Opexa Therapeutics (ACER) United States $0.032B 0.00
Bio-Path Holdings (BPTH) United States $0.031B 0.00
Iterum Therapeutics (ITRM) Ireland $0.030B 0.00
Biomerica (BMRA) United States $0.030B 0.00
Mast Therapeutics (SVRA) United States $0.029B 0.00
PharmAthene (ALT) United States $0.025B 0.00
China SXT Pharmaceuticals (SXTC) China $0.023B 0.00
ProPhase Labs (PRPH) United States $0.021B 0.00
Melinta Therapeutics (MLNT) United States $0.019B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.016B 0.00
Flex Pharma (SLRX) United States $0.015B 0.00
Heat Biologics (HTBX) United States $0.015B 0.00
Cyanotech (CYAN) United States $0.014B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.014B 0.00
Shineco (TYHT) China $0.013B 16.42
Regulus Therapeutics (RGLS) United States $0.013B 0.00
Lipocine (LPCN) United States $0.010B 0.00
HANCOCK JAFFE (HJLI) United States $0.009B 0.00
Vical (BBI) United States $0.008B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.007B 0.00
Achieve Life Sciences (ACHV) United States $0.007B 0.00
RXi Pharmaceuticals (PHIO) United States $0.006B 0.00
VAXART, INC (VXRT) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Midatech Pharma (MTP) United Kingdom $0.002B 0.00
Onconova Therapeutics (ONTX) United States $0.002B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.001B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00